Page last updated: 2024-08-23

s-2678 and Breast Neoplasms

s-2678 has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buolamwini, JK; Ma, X; Ren, S; Wang, H; Yan, C	1

Other Studies

1 other study(ies) available for s-2678 and Breast Neoplasms

Article	Year
A small-molecule inhibitor of MDMX activates p53 and induces apoptosis. Molecular cancer therapeutics, 2011, Volume: 10, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Gene Knockdown Techniques; Humans; Nuclear Proteins; Oxadiazoles; Phosphorylation; Piperazines; Promoter Regions, Genetic; Proto-Oncogene Proteins; Transfection; Tumor Suppressor Protein p53	2011

Article

Year

A small-molecule inhibitor of MDMX activates p53 and induces apoptosis.

Molecular cancer therapeutics, 2011, Volume: 10, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Gene Knockdown Techniques; Humans; Nuclear Proteins; Oxadiazoles; Phosphorylation; Piperazines; Promoter Regions, Genetic; Proto-Oncogene Proteins; Transfection; Tumor Suppressor Protein p53

2011